CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.2.1. Competitive intelligence of companies and their strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Increasing ageing population and changing lifestyle of people
3.4.1.2. Technological advancements
3.4.1.3. Changes in FDA policy
3.4.1.4. Constant rise in incidences of heart disease
3.4.2. Restraints
3.4.2.1. Availability of alternative therapies such as tissue transplantation, bypass surgery, and medicines
3.4.2.2. Complications associated with balloon catheters
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging nations
3.4.3.2. Rise in demand for minimally-invasive surgeries
3.4.4. Impact analysis
3.5. CLINICAL TRIALS
CHAPTER 4 GLOBAL PTCA BALLOON CATHETERS MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. NORMAL BALLOON CATHETERS
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. DRUG ELUTING BALLOON CATHETER
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. CUTTING BALLOON CATHETER
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. SCORING BALLOON CATHETER
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
CHAPTER 5 GLOBAL PTCA BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. OVER-THE-WIRE (OTW) BALLOON CATHETER
5.2.1. Market size and forecast
5.3. RAPID EXCHANGE(RX)/ MONORAIL BALLOON CATHETER
5.3.1. Market size and forecast
CHAPTER 6 GLOBAL PTCA BALLOON CATHETERS MARKET, BY COMPLIANCE
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. SEMI-COMPLIANT
6.2.1. Market size and forecast
6.3. NON-COMPLIANT
6.3.1. Market size and forecast
CHAPTER 7 GLOBAL PTCA BALLOON CATHETERS MARKET, BY BALLOON MATERIAL
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. POLYOLEFIN COPOLYMER (POC)
7.2.1. Market size and forecast
7.3. POLYETHYLENE (PE)
7.3.1. Market size and forecast
7.4. POLYETHYLENE TEREPHTHALATE (PET)
7.4.1. Market size and forecast
CHAPTER 8 PTCA BALLOON CATHETERS MARKET, BY REGION
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. NORTH AMERICA
8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast
8.2.4. U.S.
8.2.5. Canada
8.2.6. Mexico
8.3. EUROPE
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.3.4. Germany
8.3.5. France
8.3.6. UK
8.3.7. Italy
8.3.8. Spain
8.3.9. Rest of Europe
8.4. ASIA-PACIFIC
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.4.4. Japan
8.4.5. China
8.4.6. India
8.4.7. Australia
8.4.8. South Korea
8.4.9. Rest of Asia-Pacific
8.5. LAMEA
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
8.5.4. Brazil
8.5.5. South Africa
8.5.6. Saudi Arabia
8.5.7. Rest of LAMEA
CHAPTER 9 COMPANY PROFILES
9.1. ABBOTT LABORATORIES
9.1.1. Company overview
9.1.2. Operating business segments
9.1.3. Business performance
9.1.4. Key strategic moves and developments
9.2. B. BRAUN MELSUNGEN AG
9.2.1. Company overview
9.2.2. Operating business segments
9.2.3. Business performance
9.2.4. Key strategic moves and developments
9.3. BIOTRONIK SE & CO. KG
9.3.1. Company overview
9.3.2. Operating business segments
9.3.3. Key strategic moves and developments
9.4. BOSTON SCIENTIFIC CORPORATION
9.4.1. Company overview
9.4.2. Operating business segments
9.4.3. Business performance
9.4.4. Key strategic moves and developments
9.5. C. R. BARD, INC.
9.5.1. Company overview
9.5.2. Operating business segments
9.5.3. Business performance
9.5.4. Key strategic moves and developments
9.6. CARDINAL HEALTH, INC.
9.6.1. Company overview
9.6.2. Operating business segments
9.6.3. Business performance
9.6.4. Key strategic moves and developments
9.7. MEDTRONIC PLC
9.7.1. Company overview
9.7.2. Operating business segments
9.7.3. Business performance
9.7.4. Key strategic moves and developments
9.8. MICROPORT SCIENTIFIC CORPORATION
9.8.1. Company overview
9.8.2. Operating business segments
9.8.3. Business performance
9.8.4. Key strategic moves and developments
9.9. TERUMO CORPORATION
9.9.1. Company overview
9.9.2. Operating business segments
9.9.3. Business performance
9.9.4. Key strategic moves and developments
9.10. THE SPECTRANETICS CORPORATION
9.10.1. Company overview
9.10.2. Operating business segments
9.10.3. Business performance
9.10.4. Key strategic moves and developments